Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
Authors:
- M MazzucatoM Mazzucato
- D De RoiaDRD De Roia
- A CasonatoACA Casonato
- A B FedericiAFA B Federici
- A GirolamiAGA Girolami
- Z M RuggeriZRZ M Ruggeri
Open Access
- 1 September 1990
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 86 (3) , 785-792
Abstract
We have studied the interaction of the congenitally abnormal type IIA and IIB von Willebrand factor (vWF) molecules, both lacking the larger multimeric forms, with the two vWF binding sites on platelets, the glycoprotein (GP) Ib-IX and GP IIb-IIIa complexes. Variant as well as normal (N) vWF were purified from plasma. Estimates for binding of subunit molecules per platelet at saturation (Bmax) and dissociation constant in moles/liter (Kd), respectively, were obtained from binding isotherms of 125I-labeled vWF, with the following results. In the presence of ristocetin (binding to GP Ib-IX): N, 25,693 and 0.5 x 10(-8); IIA, both parameters not measurable; IIB, 17,708 and 0.87 x 10(-8). After thrombin stimulation (binding to GP IIb-IIIa): N, 17,059 and 1.12 x 10(-8); IIA, 23,751 and 4.87 x 10(-8); IIB, 19,890 and 2.52 x 10(-8). Distinct experiments based on measuring the ability of the variant species (from the same patients and one additional IIB patient) to inhibit the binding of normal 125I-vWF to platelets gave results in agreement with those reported above. Other studies showed that only IIB vWF bound to platelets in the absence of any mediating substance (Kd = 5.21 x 10(-8) mol/liter and Bmax = 9,599 subunits per platelet) and induced aggregation at a concentration of 10 micrograms/ml (3.6 x 10(-8) M). Thus, IIB vWF binds to GP Ib-IX with high affinity and induces platelet aggregation, whether with or without ristocetin, in spite of the absence of larger multimers. In contrast, the binding of IIA vWF to GP Ib-IX occurs with very decreased affinity, and this defective function may result from specific structural abnormalities rather than just being a reflection of the absence of larger multimeric forms. Both IIA and IIB vWF exhibit decreased affinity for GP IIb-IIIa. In this case, the extent of the defect correlates with the absence of larger multimersKeywords
This publication has 32 references indexed in Scilit:
- Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.Journal of Biological Chemistry, 1988
- Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.Proceedings of the National Academy of Sciences, 1985
- Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.Journal of Clinical Investigation, 1985
- Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.Journal of Clinical Investigation, 1985
- Platelets have more than one binding site for von Willebrand factor.Journal of Clinical Investigation, 1983
- Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.1982
- Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium bindingBiochemistry, 1981
- THE COMPLEX MULTIMERIC COMPOSITION OF FACTOR-VIII-VONWILLEBRAND FACTOR1981
- EFFECT OF THE MULTIMERIC STRUCTURE OF THE FACTOR VIII-VON WILLEBRAND FACTOR PROTEIN ON BINDING TO PLATELETS1981
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980